Asia-Pacific bioceramics market is estimated to grow at a CAGR of 7.2% during the forecast period. The expansion of implants manufacturers is one of the key factors in accelerating the growth of the market. Key implant manufacturers, including the Straumann Group and Medtronic plc, have accelerated investment in their implant portfolios in major Asia Pacific markets. For instance, in July 2019, the Straumann Group signed a collaboration agreement with Yuhan Corp., to expand the global business of Warantec, which is an established Korean implant brand. In Warantec, Yuhan holds a controlling stake. Under the agreement, Straumann will provide some capital to set up Warantec’s manufacturing and global business.
(Get 16% Discount on Buying this Report)
Get Sample Copy @ https://www.omrglobal.com/request-sample/asia-pacific-bioceramics-market
In Warantec, Straumann will be granted 33.5% shareholding and exclusive distribution rights to its products outside Korea. This will enable Straumann to increase its reach in the non-premium implant segment. Further, in 2016, the Straumann Group acquired Equinox, a renowned Indian implant brand. The increasing focus of major implants manufacturers in Asia-Pacific is expected to widen the opportunity for the adoption of bioceramics that acts as a biocompatible material along with high strength and wear resistance. These properties make bioceramics ideal to strengthen the properties of medical implants.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/asia-pacific-bioceramics-market
The market is segmented based on product type and application. Based on product type, the market is segmented into bio-inert, bio-active, and bio-resorbable. Based on the application, the market is segmented into dental, orthopedic, and others. A significant rise in orthopedic procedures coupled with the huge presence of the geriatric population base is driving the demand for orthopedic implants in the region. As per the Japanese Society for Replacement Arthroplasty, in 2016, there were a total of 88,146 primary and revision arthroplasty procedures performed in Japan. Therefore, it is expected that the orthopedic implants’ manufacturing base will accelerate in the region, in turn, will further increase the demand for bioceramics in the region.
Some key players in the market include CeramTec GmbH, Straumann AG, Kyocera Corp., NGK Spark Plug Co., Ltd., and Kuraray Europe GmbH. The market players are using strategies such as product launches, mergers & acquisitions, partnerships and collaborations, and geographical expansion, to gain a competitive advantage. For instance, in February 2019, Kyocera Fineceramics GmbH, a division of Kyocera Corp. signed an agreement to acquire 100% shares of H.C. Starck subsidiary H.C. Starck Ceramics GmbH, a Germany-based manufacturer of advanced ceramics. In spring 2019, H.C. Starck Ceramics will combine into Kyocera Group, subject to regulatory approval. This acquisition will enable Kyocera to respond faster to clients in Europe.
Asia-Pacific Bioceramics Market by Product Type
- Glass Ceramics
Asia-Pacific Bioceramics Market by Application
- Rest of Asia-Pacific
- Bloomden Bioceramics Co., Ltd.
- CeramTec GmbH
- CoorsTek Inc.
- Dentsply Sirona Inc.
- IFGL Refractories Ltd.
- Jyoti Ceramic Industries Pvt. Ltd.,
- Kuraray Europe GmbH
- Kyocera Corp.
- NGK Spark Plug Co., Ltd.
- Saint-Gobain Group
- Straumann AG
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-bioceramics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404